These reagents are being developed both in preclinical models and in the clinic in Southampton. Professor Glennie is an adjunct Professor to the Dartmouth Medical School, NH, a visiting Professor at the Scripps Research Institute, CA, and consults for the biotech industry in Europe and the US. He is also […]
diabetes
This opens up the possibility of refining agonistic activity by engineering reagents which bind with the correct affinity to this receptor. A key benefit of seeking treatment from us is being able to access the resources of Yale University and Yale New Haven Hospital. “Oftentimes, one approach doesn’t work in […]
We hand-deliver your medications at the time and location that works best for you. National organizations may provide information on the regulation of pharmacy practice in other states. The division has expanded our online services to allow licensees to download their own license certificates on demand. As a result, the […]
Immunostimulatory monoclonal antibodies became newsworthy when the drug ipilimumab proved effective against metastatic melanoma and was approved for patients by the Food and Drug Administration. They have gone on to develop an engineered anti-CD40 monoclonal antibody (ChiLob7-4), which has now completed phase I trials. It appears that these reagents work […]